...
首页> 外文期刊>International Journal of Cardiology >Oestradiol supplement minimises coronary occlusion-induced myocardial infarction and ventricular dysfunction in oophorectomised female rats.
【24h】

Oestradiol supplement minimises coronary occlusion-induced myocardial infarction and ventricular dysfunction in oophorectomised female rats.

机译:雌二醇补充剂可最大程度地减少经去卵巢切除的雌性大鼠的冠状动脉阻塞引起的心肌梗塞和心室功能障碍。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Endogenous oestrogen deficiency after menopause is associated with high risk of acute cardiac events and the protection of exogenous oestrogen supplements remains uncertain. This study investigates whether oestrogen therapy protects the heart from ischemic injury in oophorectomised rats. METHODS: Sexually mature female Sprague-Dawley rats (6 for each group) with bilateral oophorectomy underwent selective ligation (occlusion) of left coronary artery for 4 weeks. 17beta-oestradiol (E2) supplements (10 mug, i.m., every other day) were started before (preventive-therapeutic supplement) or after coronary occlusion (therapeutic supplement). RESULTS: In oophorectomised rats plasma levels of E2 declined from 1301 +/- 80 to 196 +/- 48 pmol/L (p<0.01) and cardiac expression of oestrogen receptors (ER) decreased by approximately 60%. E2 supplements recovered the ER expression. Selective ligation of left coronary led myocardial infarction in the left ventricle, with an increase in plasma cardiac troponin I (cTn-I), decrease in systolic blood pressure (SBP), and reduction of left ventricular pressures. Preventive-therapeutic but not therapeutic E2 supplement reduced cTn-I levels (from 21.9 +/- 2.0 to 6.0 +/- 0.3 ng/mL, p<0.01), minimised infarction (from 37.0 +/- 1.2% to 18.1 +/- 2.3%, p<0.05), increased SBP (from 82 +/- 4.2 to 97 +/- 4.4mm Hg, p<0.05), and improved left ventricular end pressures in the oophorectomised rats following coronary occlusion. CONCLUSION: Postmenopausal (ooporectomised) oestrogen supplement commenced before establishment of myocardial ischemia minimises myocardial infarction and ventricular dysfunction following the coronary artery occlusion. Cellular and molecular mechanisms underlying the cardiac protection of oestrogen therapy remain unclear, in which activation of cardiac ER expression and increasing in circulating CD90(+) stem cells may be involved.
机译:背景:绝经后内源性雌激素缺乏与急性心脏事件的高风险相关,外源性雌激素补充剂的保护仍不确定。这项研究调查了雌激素治疗是否可以保护经卵巢切除的大鼠的心脏免受缺血性损伤。方法:对性成熟的雌性Sprague-Dawley大鼠(每组6只)进行双侧卵巢切除术,进行选择性结扎(闭塞)左冠状动脉4周。 17beta-雌二醇(E2)补充剂(10杯,隔天一次,隔天一次)在冠状动脉闭塞之前(预防性补充剂)或之后开始(补充性治疗剂)。结果:在切除卵巢的大鼠中,血浆E2水平从1301 +/- 80降低至196 +/- 48 pmol / L(p <0.01),雌激素受体(ER)的心脏表达降低约60%。 E2补充剂恢复了ER表达。左心室中左冠状动脉导致的心肌梗死的选择性结扎,血浆心肌肌钙蛋白I(cTn-I)升高,收缩压(SBP)降低,左心室压力降低。预防性而非治疗性E2补充剂可降低cTn-I水平(从21.9 +/- 2.0降低至6.0 +/- 0.3 ng / mL,p <0.01),将梗塞最小化(从37.0 +/- 1.2%降至18.1 +/- 2.3%,p <0.05),SOP升高(从82 +/- 4.2到97 +/- 4.4mm Hg,p <0.05),并改善了冠状动脉闭塞后切除卵巢的大鼠的左心室末端压力。结论:绝经后(切除卵巢)雌激素补充剂在心肌缺血建立之前开始,可最大程度地减少冠状动脉闭塞后的心肌梗塞和心室功能障碍。尚不清楚心脏保护雌激素治疗的细胞和分子机制,其中可能涉及心脏ER表达的激活和循环CD90(+)干细胞的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号